PRAME and uveal melanoma: A recent study showed that the expression of the oncogene PRAME in a group of uveal melanoma patients allowed the identification of a group of class 1 patients with intermediate metastatic risk, and these uveal melanomas often harbor SF3B1 mutations [144].